BioSpace News Archive

Business

AbbVie Taps Harvard University for Viral Infection Research Partnership

AbbVie and Harvard University entered into a $30 million collaborative research alliance to develop therapies against emergent viral infections, with a focus on those caused by coronaviruses and by viruses that lead to hemorrhagic fever.

August 25, 2020
·
2 min read
·
Alex Keown
Business

Biogen Conference Led to 20,000 COVID-19 Cases, Study Suggests

A new, 64-page study that has not been peer-reviewed, extrapolates the number of infections that stemmed from the company’s corporate meeting held at the Marriott Long Wharf hotel in February.

August 25, 2020
·
2 min read
·
Alex Keown
Drug Development

Ipsen to Present Results From MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP), at ASBMR 2020 Annual Meeting

Ipsen announced results from the MOVE trial, the first and only multicenter Phase III study in fibrodysplasia ossificans progressiva, to be presented during an oral presentation at the American Society for Bone and Mineral Research 2020 annual meeting.

August 25, 2020
·
13 min read
Genetown

SCIEX Announces Establishment of UK Centre of Innovation

SCIEX to establish UK Centre of Innovation at Alderley Park Bio Hub to enhance customer support and application development capabilities

August 25, 2020
·
2 min read
Business

AlzeCure publishes its interim report for January - June 2020

AlzeCure Pharma AB announced that its interim report for the period January - June 2020 is now available on the company’s website: https://www.alzecurepharma.se/en/section/investors/financial-reports/

August 25, 2020
·
5 min read
Policy

Gyroscope Therapeutics Announces FDA Clearance for Orbit Subretinal Delivery System

Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, announced that the U.S. Food & Drug Administration has granted 510 clearance for the Orbit™ Subretinal Delivery System.

August 25, 2020
·
2 min read
The Brain Protection Company Awarded $1M Research Grant To Pursue Novel Approach To Treat Alzheimer’s Disease

The Brain Protection Company Pty Ltd announced it has been awarded a US$1 million grant from the Part the Cloud – Bill Gates Partnership Grant Program, whose mission is to fund Alzheimer’s research with the highest probability of slowing, stopping or curing the disease.

August 25, 2020
·
4 min read
First LIVE Coronavirus sample tested successfully with OTSAW UV-C LED disinfection robot

OTSAW has built the world’s first successfully laboratory tested human Coronavirus exterminating machine using OTSAW’s patented UV-C LED, the O-RX.

August 25, 2020
·
1 min read
Business

Calliditas appoints Group General Counsel

Calliditas Therapeutics AB announced the appointment of Jonathan Schur as Group General Counsel, effective October 1, 2020.

August 25, 2020
·
3 min read
Deals

Diaprost AB Acquires Rights to use of PSA Antibodies from Leading New York Cancer Center

Diaprost announced that it has signed an exclusive license agreement with Memorial Sloan Kettering Cancer Center for IP related to the use of PSA antibodies for therapeutic and diagnostic purposes for prostate cancer.

August 25, 2020
·
2 min read